Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Works by Oliva, E. N.
Results: 2
1
2
Twice-Weekly High-Dose rHuEpo for the Treatment of Anemia in Patients with Low-Risk Myelodysplastic Syndromes.
- Published in:
- Acta Haematologica, 2008, v. 120, n. 2, p. 104, doi. 10.1159/000166864
- By:
- Publication type:
- Article